{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T21:42:50Z","timestamp":1773697370472,"version":"3.50.1"},"reference-count":51,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2022,7,5]],"date-time":"2022-07-05T00:00:00Z","timestamp":1656979200000},"content-version":"vor","delay-in-days":185,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["BioMed Research International"],"published-print":{"date-parts":[[2022,1]]},"abstract":"<jats:p><jats:italic>Background<\/jats:italic>. Breast cancer is one of the most common types of cancer diagnosed and the second leading cause of death among women. Breast cancer susceptibility proteins of type 1 and 2 are human tumor suppressor genes. Genetic variations\/mutations in these two genes lead to overexpression of human breast tumor suppressor genes (e.g., BRCA1, BRCA2), which triggers uncontrolled duplication of cells in humans. In addition, multidrug resistance protein 1 (MDR1), an important cell membrane protein that pumps many foreign substances from cells, is also responsible for developing resistance to cancer chemotherapy. <jats:italic>Aim of the Study<\/jats:italic>. The aim of this study was to analyze some natural compounds or their derivatives as part of the development of strong inhibitors for breast cancer. <jats:italic>Methodology<\/jats:italic>. Molecular docking studies were performed using compounds known in the literature to be effective against BRCA1 and BRCA2 and MDR1, with positive control being 5\u2010fluorouracil, an antineoplastic drug as a positive control. <jats:italic>Results<\/jats:italic>. The binding affinity of the compounds was analyzed, and it was observed that they had a better binding affinity for the target proteins than the standard drug 5\u2010fluorouracil. Among the compounds analyzed, <jats:italic>\u03b1<\/jats:italic>\u2010hederin, andrographolide, apigenin, asiatic acid, auricular acid, sinularin, curcumin, citrinin, hispolon, nerol, phytol, retinol palmitate, and sclareol showed the best binding affinity energy to the BRCA1, BRCA2, and MDR1 proteins, respectively. <jats:italic>Conclusions<\/jats:italic>. <jats:italic>\u03b1<\/jats:italic>\u2010Hederin, andrographolide, apigenin, asiatic acid, auricular acid, hispolon, sclareol, curcumin, citrinin, and sinularin or their derivatives can be a good source of anticancer agents in breast cancer.<\/jats:p>","DOI":"10.1155\/2022\/5886269","type":"journal-article","created":{"date-parts":[[2022,7,5]],"date-time":"2022-07-05T23:20:06Z","timestamp":1657063206000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["Natural Compounds or Their Derivatives against Breast Cancer: A Computational Study"],"prefix":"10.1155","volume":"2022","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4773-8320","authenticated-orcid":false,"given":"Rajib","family":"Hossain","sequence":"first","affiliation":[]},{"given":"Pranta","family":"Ray","sequence":"additional","affiliation":[]},{"given":"Chandan","family":"Sarkar","sequence":"additional","affiliation":[]},{"given":"Md. Shahazul","family":"Islam","sequence":"additional","affiliation":[]},{"given":"Rasel Ahmed","family":"Khan","sequence":"additional","affiliation":[]},{"given":"Abul Bashar Ripon","family":"Khalipha","sequence":"additional","affiliation":[]},{"given":"Muhammad Torequl","family":"Islam","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4174-4586","authenticated-orcid":false,"given":"William C.","family":"Cho","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3183-7623","authenticated-orcid":false,"given":"Miquel","family":"Martorell","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7301-8151","authenticated-orcid":false,"given":"Javad","family":"Sharifi-Rad","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2032-5000","authenticated-orcid":false,"given":"Monica","family":"Butnariu","sequence":"additional","affiliation":[]},{"given":"Almagul","family":"Umbetova","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1523-9116","authenticated-orcid":false,"given":"Daniela","family":"Calina","sequence":"additional","affiliation":[]}],"member":"311","published-online":{"date-parts":[[2022,7,5]]},"reference":[{"key":"e_1_2_8_1_2","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.32023"},{"key":"e_1_2_8_2_2","doi-asserted-by":"publisher","DOI":"10.1158\/1538-7445.SABCS19-P2-05-04"},{"key":"e_1_2_8_3_2","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2019.9933"},{"key":"e_1_2_8_4_2","first-page":"683","article-title":"Immunohistochemical expression of TGF beta (TGF-\u03b2), TGF beta receptor 1 (TGFBR1), and Ki67 in intestinal variant of gastric adenocarcinomas","volume":"53","author":"Docea A. O.","year":"2012","journal-title":"Romanian Journal of Morphology and Embryology"},{"key":"e_1_2_8_5_2","doi-asserted-by":"publisher","DOI":"10.1038\/nm0497-447"},{"key":"e_1_2_8_6_2","doi-asserted-by":"publisher","DOI":"10.1136\/mp.51.5.237"},{"key":"e_1_2_8_7_2","first-page":"265","article-title":"Breast and ovarian cancer incidence in BRCA1-mutation carriers. Breast cancer linkage consortium","volume":"56","author":"Easton D. F.","year":"1995","journal-title":"American Journal of Human Genetics"},{"key":"e_1_2_8_8_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.1088759"},{"key":"e_1_2_8_9_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.7545954"},{"key":"e_1_2_8_10_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1209872"},{"key":"e_1_2_8_11_2","doi-asserted-by":"publisher","DOI":"10.1158\/1541-7786.MCR-05-0192"},{"key":"e_1_2_8_12_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1349-7006.2004.tb02195.x"},{"key":"e_1_2_8_13_2","doi-asserted-by":"publisher","DOI":"10.1002\/jcb.10469"},{"key":"e_1_2_8_14_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.8091231"},{"key":"e_1_2_8_15_2","volume-title":"The Genetic Information Nondiscrimination Act","author":"Joseph S.","year":"2013"},{"key":"e_1_2_8_16_2","unstructured":"Williams-JonesB. Genetic Testing for Sale: Implications of Commercial BRCA Testing in Canada [Ph.D. thesis] 2002 University of British Columbia Political Science."},{"key":"e_1_2_8_17_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6600008"},{"key":"e_1_2_8_18_2","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-7-152"},{"key":"e_1_2_8_19_2","first-page":"10","article-title":"Expression of Brca1 in a group of Iraqi patients with breast cancer","volume":"13","author":"Sattar S. A.","year":"2018","journal-title":"IOSR Journal of Pharmacy and Biological Sciences"},{"key":"e_1_2_8_20_2","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/3687700"},{"key":"e_1_2_8_21_2","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/89.13.917"},{"key":"e_1_2_8_22_2","first-page":"243","article-title":"Mechanisms of hormone and cytotoxic drug interactions in the development and treatment of breast cancer","volume":"322","author":"Clarke R.","year":"1990","journal-title":"Progress in Clinical and Biological Research"},{"key":"e_1_2_8_23_2","first-page":"441","article-title":"Effect of tamoxifen on the multidrug-resistant phenotype in human breast cancer cells: isobologram, drug accumulation, and M(r) 170,000 glycoprotein (gp170) binding studies","volume":"54","author":"Leonessa F.","year":"1994","journal-title":"Cancer Research"},{"key":"e_1_2_8_24_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-021-02025-4"},{"key":"e_1_2_8_25_2","doi-asserted-by":"publisher","DOI":"10.1177\/147323001204000204"},{"key":"e_1_2_8_26_2","doi-asserted-by":"publisher","DOI":"10.2174\/187152013804487380"},{"key":"e_1_2_8_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.molcel.2015.12.017"},{"key":"e_1_2_8_28_2","doi-asserted-by":"publisher","DOI":"10.1038\/embor.2009.126"},{"key":"e_1_2_8_29_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.aar7389"},{"key":"e_1_2_8_30_2","doi-asserted-by":"publisher","DOI":"10.1080\/07391102.2020.1772109"},{"key":"e_1_2_8_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmpb.2020.105494"},{"key":"e_1_2_8_32_2","doi-asserted-by":"publisher","DOI":"10.1007\/s12013-014-0153-8"},{"key":"e_1_2_8_33_2","doi-asserted-by":"publisher","DOI":"10.1007\/s13277-016-5329-y"},{"key":"e_1_2_8_34_2","doi-asserted-by":"publisher","DOI":"10.1080\/07391102.2020.1720818"},{"key":"e_1_2_8_35_2","doi-asserted-by":"publisher","DOI":"10.1080\/07391102.2019.1696709"},{"key":"e_1_2_8_36_2","doi-asserted-by":"publisher","DOI":"10.1080\/07391102.2021.1900918"},{"key":"e_1_2_8_37_2","doi-asserted-by":"publisher","DOI":"10.1002\/jcb.28387"},{"key":"e_1_2_8_38_2","doi-asserted-by":"publisher","DOI":"10.2174\/138161210791164063"},{"key":"e_1_2_8_39_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00044-010-9398-y"},{"key":"e_1_2_8_40_2","doi-asserted-by":"publisher","DOI":"10.1080\/10629360310001623935"},{"key":"e_1_2_8_41_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.compbiomed.2014.01.003"},{"key":"e_1_2_8_42_2","unstructured":"PubChem 2021 PubChem.https:\/\/pubchem.ncbi.nlm.nih.gov\/."},{"key":"e_1_2_8_43_2","doi-asserted-by":"publisher","DOI":"10.1186\/s40064-016-2996-5"},{"key":"e_1_2_8_44_2","doi-asserted-by":"publisher","DOI":"10.1016\/0020-1693(95)04648-8"},{"key":"e_1_2_8_45_2","unstructured":"DelanoW. L. The PyMOL molecular graphics system 2002 http:\/\/www.pymol.org."},{"key":"e_1_2_8_46_2","doi-asserted-by":"publisher","DOI":"10.1002\/jcc.21334"},{"key":"e_1_2_8_47_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0707305"},{"key":"e_1_2_8_48_2","doi-asserted-by":"publisher","DOI":"10.3390\/molecules26226821"},{"key":"e_1_2_8_49_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2020.103756"},{"key":"e_1_2_8_50_2","doi-asserted-by":"publisher","DOI":"10.1002\/pro.540"},{"key":"e_1_2_8_51_2","doi-asserted-by":"publisher","DOI":"10.1517\/17460441.2013.761204"}],"container-title":["BioMed Research International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/downloads.hindawi.com\/journals\/bmri\/2022\/5886269.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/downloads.hindawi.com\/journals\/bmri\/2022\/5886269.xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1155\/2022\/5886269","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:20:15Z","timestamp":1735690815000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1155\/2022\/5886269"}},"subtitle":[],"editor":[{"given":"Mohammad","family":"Nazim","sequence":"additional","affiliation":[]}],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":51,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["10.1155\/2022\/5886269"],"URL":"https:\/\/doi.org\/10.1155\/2022\/5886269","archive":["Portico"],"relation":{},"ISSN":["2314-6133","2314-6141"],"issn-type":[{"value":"2314-6133","type":"print"},{"value":"2314-6141","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"2021-09-15","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-06-21","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-07-05","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"5886269"}}